Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- Dr. Georgi Abraham received the Karl Nolph Lifetime Achievement Award for PD Posted 03-12-2026
- Pittsburgh WPXI News Shares Impact of Recent Snowstorm on Dialysis Posted 02-17-2026
- Justin Pham Started HD Emergently and Switched to PD Posted 11-11-2025
- Strive Health Receives $550 million to Expand Services and Partnerships Posted 10-14-2025